Intralesional and topical chemotherapy and immunotherapy.
- Journal Article
- Review
Summary
The research article explores the benefits of conservative treatment modalities – specifically local chemotherapy and immunotherapy – in treating equine tumors. The study suggests that these methods are not only effective but also have minimal impact on normal tissue.
Conservative Treatment Modalities
In treating equine tumors, often the first line of treatment is surgery. But on certain occasions, to preserve the function and appearance, conservative treatment is preferred. This research article explores the effectiveness and application of two conservative treatment methods:
- Local Chemotherapy
- Immunotherapy
Local Chemotherapy
Local chemotherapy is based on delivering drugs directly to the tumor, either topically or through intratumoral administration of cytotoxic agents in slow-release formulations. The benefits of local chemotherapy highlighted by this research are:
- Direct drug delivery targets the tumor more effectively, increasing the impact of the treatment.
- It is particularly effective for cutaneous (skin-related) tumors.
- The administration of therapeutic agents directly to the tumor minimizes their interaction with normal tissue, hence minimizing the risk of causing permanent damage.
Immunotherapy
Immunotherapy works against tumors by enhancing the body’s natural defense mechanisms to fight off cancer cells. Even though the research around immunotherapy’s effectiveness in treating equine tumors is ongoing, the article does provide examples of successful implementation. The notable features of immunotherapy are:
- It enhances the host’s (patient’s) natural defenses, making it a more organic and less intrusive method.
- Immunotherapy presents potential for the future with further research and trials to establish its effectiveness in a broader context.
Cite This Article
Publication
Researcher Affiliations
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, USA.
MeSH Terms
- Animals
- Horse Diseases / drug therapy
- Horse Diseases / therapy
- Horses
- Immunotherapy / veterinary
- Skin Neoplasms / drug therapy
- Skin Neoplasms / therapy
- Skin Neoplasms / veterinary
Citations
This article has been cited 2 times.- Wang L, Unger L, Sharif H, Eriksson S, Gerber V, Rönnberg H. Molecular characterization of equine thymidine kinase 1 and preliminary evaluation of its suitability as a serum biomarker for equine lymphoma.. BMC Mol Cell Biol 2021 Dec 14;22(1):59.
- Finlay M, Yuan Z, Morgan IM, Campo MS, Nasir L. Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53.. Vet Res 2012 Dec 4;43(1):81.